IP Verse

Von Seebach, Malte opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Von Seebach, Malte

Patent Number:
EP3453387
Title:
Dosage Regimen For A S1P Receptor Agonist
Applicant:
NOVARTIS AG
Opposition Date:
Mar 3, 2021
Patent Number:
EP3409274
Title:
Dosage Regimen For A S1P Receptor Agonist
Applicant:
NOVARTIS AG
Opposition Date:
Aug 18, 2020
Patent Number:
EP3246021
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Opposition Date:
Aug 6, 2020

Competitors of Von Seebach, Malte

NOVARTIS AG

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND

BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY

Want to track Von Seebach, Malte?

Feel free to send us a message here and we will get back to you